Why AbbVie Is a Strong Buy for Long-Term Investors in 2025

  • AbbVie Inc. (ABBV) has emerged as a strong performer in financial and technical terms, attracting investor attention due to its long-term growth potential. With consistent revenue generation and expansion of its immunology and neuroscience portfolios, the company demonstrates operational strength.